Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium pMDI vs Spiriva Respimat pharmacokinetics in healthy volunteers
NCT03246581Phase 1Completed
- Sponsor
- Kindeva Drug Delivery
- Start
- Jul 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tiotropium (2 arms), sponsored by Kindeva Drug Delivery. Primary endpoint: Peak Plasma Concentration at 24 hours. Started Jul 2017; status: completed.
02
Drugs
tiotropium
Beyond the preview
Go deeper on NCT03246581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03246581.